LONG ACTING CORONARY VASODILATOR DRUGS-PRINCIPLES OF CLINICAL USE AS DETERMINED BY KINETOCARDIOGRAM

被引：0
|
作者：
LANGLEY, J
机构：
来源：
TEXAS REPORTS ON BIOLOGY AND MEDICINE | 1964年 / 22卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：787 / &
相关论文
共 50 条
  • [41] Clinical Considerations for Long-acting Injectable Risperidone's Use on Cocaine Dependence and Dual Diagnosis
    Haro, Gonzalo
    Ripoll, Carmen
    Crespo, Alvaro
    Gilabert, Maria Sales
    Lleo, Eva
    Calabuig, Maria
    Orengo, Teresa
    ADDICTIVE DISORDERS & THEIR TREATMENT, 2011, 10 (03): : 93 - 100
  • [42] Paliperidone palmitate long-acting injection - prospective year-long follow-up of use in clinical practice
    Attard, A.
    Olofinjana, O.
    Cornelius, V.
    Curtis, V.
    Taylor, D.
    ACTA PSYCHIATRICA SCANDINAVICA, 2014, 130 (01) : 46 - 51
  • [43] Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?
    Parkin, Lianne
    Williams, Sheila
    Barson, David
    Sharples, Katrina
    Horsburgh, Simon
    Jackson, Rod
    Dummer, Jack
    BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)
  • [44] Inferiority of calcium channel blockers to cheaper drugs - Use of long acting calcium channel blockers is not deleterious in elderly hypertensive patients
    Cockcroft, JR
    Wilkinson, IB
    BRITISH MEDICAL JOURNAL, 2001, 322 (7287): : 672 - 672
  • [45] Low-Barrier Long-Acting Injectable Antiretrovirals for HIV Treatment and Prevention Among People Who Use Drugs
    Mehtani, Nicky
    Strough, Alix
    Strieff, Sarah
    Martinez, Consuelo
    Zevin, Barry
    Eveland, Joanna
    Gandhi, Monica
    DRUG AND ALCOHOL DEPENDENCE, 2025, 267
  • [46] Clinical and demographic predictors of long acting-injectable antipsychotic drugs discontinuation in subjects with psychotic disorders: a retrospective observational study
    Tringali, A. G. M.
    Caldiroli, A.
    Capuzzi, E.
    Carnevali, G.
    Clerici, M.
    Buoli, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S558 - S559
  • [47] Long acting paliperidone palmitate - a service evaluation of its use in clinical practice and its effects on hospital stay
    Pappa, S.
    Sahib, L.
    Larkin, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S502 - S503
  • [48] Use of long-acting injectable antipsychotics in an early intervention service: Socio-demographic and clinical variables
    Vitas Boas Garcia, S.
    Pinto, I.
    Pereira, C.
    Caldas, I.
    Teodoro, T.
    Salgado, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S468 - S468
  • [49] Guidance on the clinical understanding and use of long-acting injectable antipsychotics in Schizophrenia: Hong Kong Consensus Statements
    Wong, Michael Ming Cheuk
    Chung, Albert Kar Kin
    Yeung, Timothy Ming Hong
    Wong, David Tai Wai
    Lee, Che Kin
    Lai, Eric
    Chan, Gloria Fong Yeung
    Mak, Gregory Kai Lok
    Wong, Jessica Oi Yin
    Ng, Roger Man Kin
    Mak, Ki Yan
    CNS NEUROSCIENCE & THERAPEUTICS, 2021, 27 : 5 - 11
  • [50] Use of Long-Acting Injectable Antipsychotic Medication in Youth at Winnebago Mental Health Institute: A Clinical Pathway
    Scharko, Alexander M.
    Mireski, Sarah J.
    Casimir, Kenneth
    Goldstein, Benjamin
    Monese, George
    Pope, Kayla
    Taleon, Andrea
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2025, 35 (02) : 111 - 113
12345